A recent study explores the important role of gut microbiota in the development and management of diabetes mellitus (DM), specifically type 2 diabetes (T2DM). The study found that T2DM patients had compositional changes in their gut microbiota, including lower levels of certain bacteria and increased presence of pathogens. Dysbiosis of the gut microbiome can impact various molecular mechanisms involved in the pathogenesis of T2DM. Therapeutic approaches targeting the gut microbiota, such as probiotics, synbiotics, and fecal microbiota transplantation, have shown promising results in improving glycemic control and insulin sensitivity. Further research is needed to better understand and develop personalized interventions for managing T2DM.
Source link
A new approach to treating diabetes
